Loading company…
WellThera develops an ultrasound-based system for targeted drug delivery.
WellThera is developing its Bubble Ultrasound-mediated Drug Delivery System (BUS-DDS) to improve delivery of therapeutic agents, particularly chemotherapeutics. Founded in 2018 and based in Tokyo, Japan, it raised JPY 23.1 million in Series A funding from Knowledge Initiative for Teikyo Technology on January 15, 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in